|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 413/14 | |
| A61K 31/422 | |||
| A61K 31/4439 | |||
| A61P 35/00 | |||
| A61P 37/00 | |||
| A61P 11/00 | |||
| A61P 31/12 |
| (11) | Patento numeris | 3260453 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17182412.1 |
| Europos patento paraiškos padavimo data | 2010-04-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-12-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-03-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 174033 P | 2009-04-30 | US |
| (72) |
HAMBLIN, Julie Nicole, GB
JONES, Paul Spencer, GB
KEELING, Suzanne Elaine, GB
LE, Joelle, GB
MITCHELL, Charlotte Jane, GB
PARR, Nigel James, GB
|
| (73) |
Glaxo Group Limited,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
|
| (54) | OXAZOLE SUBSTITUTED INDAZOLES AS PI3-KINASE INHIBITORS |
| OXAZOLE SUBSTITUTED INDAZOLES AS PI3-KINASE INHIBITORS |